These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38332893)

  • 1. Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy.
    Zhou D; Zhou T; Tang S; Li Q; Li W; Gan G; Li M; Chen Q
    Front Endocrinol (Lausanne); 2024; 15():1354950. PubMed ID: 38332893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
    Fu S; Zhou Y; Hu C; Xu Z; Hou J
    BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
    Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
    J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy.
    Zain M; Awan FR
    Pak J Pharm Sci; 2014 Sep; 27(5):1379-91. PubMed ID: 25176370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
    Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
    Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data.
    Liu Y; Cui X; Zhang X; Xie Z; Wang W; Xi J; Xie Y
    Front Endocrinol (Lausanne); 2023; 14():1172226. PubMed ID: 38027201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.
    Liu MM; Lv NN; Geng R; Hua Z; Ma Y; Huang GC; Cheng J; Xu HY
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):274-289. PubMed ID: 33588742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
    Fan C; Gao Y; Sun Y
    Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and
    Han Y; Wei S; Liu C; Nie Y; Yuan S; Ma Y; Zhao Y; Zhang G
    Comb Chem High Throughput Screen; 2024; 27(14):2078-2089. PubMed ID: 37861047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
    Gui H; Chen X; Ye L; Ma H
    Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the Potential Mechanism of Triptolide in Improving Diabetic Nephropathy by Utilizing A Network Pharmacology and Molecular Docking Approach.
    An X; Fan D; Yin Z; Zhang J; Zhou Y; Tian R; Yan M
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):94. PubMed ID: 35345326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis.
    Lin YQ; Yu F; Chen HJ; Deng YR; Lin J; Xu Y; Zheng X; Zhang JW; Liu JF
    Ren Fail; 2024 Dec; 46(2):2359033. PubMed ID: 38836372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
    Ming J; Sana SRGL; Deng X
    Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy.
    Yan M; Li W; Wei R; Li S; Liu Y; Huang Y; Zhang Y; Lu Z; Lu Q
    J Transl Med; 2023 Jul; 21(1):490. PubMed ID: 37480090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.